FBDT

FBDT

CIK 0001892704

No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (IREN 10-K) is open in full — no account needed.

10-Q Filed Aug 28, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 25, 2026 · Period ending Aug 25, 2026

Summary not yet generated.

Partner

Trade FBDT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B4 Filed Aug 20, 2026

Summary not yet generated.

S-1/A Filed Aug 7, 2026

Summary not yet generated.

S-1/A Filed Aug 3, 2026

Summary not yet generated.

S-1/A Filed Jun 12, 2026

Summary not yet generated.

S-1 Filed Apr 30, 2026

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 28, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Statements of Operations (Unaudited)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Net revenues 95,353 95,219 361,357 110,905
Cost of revenues 605,866 592,348 1,235,716 919,844
Net loss associated with liquidation of raw materials 298,771 684,960
Gross margin (510,513) (795,900) (874,359) (1,493,899)
Operating expenses:
Selling, general, and administrative expense 11,202,485 873,299 25,288,394 1,345,881
Research and development 126,313 126,313
Total operating expenses 11,328,798 873,299 25,414,707 1,345,881
Loss from operations (11,839,311) (1,669,199) (26,289,066) (2,839,780)
Other expense, net:
Interest expense, net (1,860,323) (582,123) (2,004,679) (988,452)
Amortization of deferred financing costs (191,590) (191,590)
Change in fair value of warrant liability 45,094 45,094
Loss on sale of assets (16,758) (1,906) (56,215) (1,906)
Other income 25,500 42,500
Other expense (13,389) (10,260) (26,776) (20,525)
Total other expense, net (2,036,966) (568,789) (2,234,166) (968,383)
Net loss before income taxes (13,876,277) (2,237,988) (28,523,232) (3,808,163)
Income tax provision
Net loss (13,876,277) (2,237,988) (28,523,232) (3,808,163)
Net loss per share:
Basic and diluted (0.26) (0.06) (0.54) (0.10)
Weighted average number of shares outstanding
Basic and diluted 54,112,845 37,784,611 52,767,635 37,784,611

Condensed Balance Sheets (Unaudited)

Description June 30, 2026 (Unaudited) December 31, 2025
Assets
Current Assets
Cash 4,923,504 2,477,122
Accounts receivable 26,584 51,889
Inventories, net 787,479 918,359
Prepaid assets 1,255,080 46,192
Total Current Assets 6,992,647 3,493,562
Property and equipment, net 9,258,482 8,201,957
Right-of-use assets 1,093,493 1,271,638
Other assets 273,622 53,625
Total assets 17,618,244 13,020,782
Liabilities and stockholders’ equity
Current Liabilities
Accounts payable 1,321,695 2,041,908
Accrued liabilities 413,216 431,659
Accrued liabilities, related party 428,278
Employee loan payable, related party 121,739 121,739
Note payable related party 50,000 50,000
Note payable current portion 7,166
Convertible notes payable, net of debt discount current portion 9,348,543 284,146
Warrant liability, at fair value 2,547,702
Operating lease liability current portion 387,521 372,665
Financing lease liability current portion 1,037,003 893,710
Total current liabilities 15,227,419 4,631,271
Long-term liabilities:
Note payable 27,523
Convertible notes payable, net of debt discount 201,215
Operating lease liability net of current portion 791,469 988,471
Financing lease liability net of current portion 229,697 767,822
Total liabilities 16,248,585 6,616,302
Commitments and contingencies (Note 17)
Stockholders’ equity
Preferred stock, $0.0001 par value, 1,000,000 authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock, $0.0001 par value, 500,000,000 and 100,000,000 authorized, 49,152,702 and 44,500,111 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively 4,915 4,450
Additional paid-in capital 65,131,098 41,643,152
Accumulated deficit (63,766,354) (35,243,122)
Total stockholders’ equity 1,369,659 6,404,480
Total liabilities and stockholders’ equity 17,618,244 13,020,782

Condensed Statements of Cash Flows (Unaudited)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net loss (28,523,232) (3,808,163)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation 21,962,399
Issuance of stocks for services 184,008
Depreciation and amortization 682,374 665,743
Amortization of debt discount 129,278 135,565
Amortization of debt discount warrant feature and OID interest 1,559,510 433,458
Change in fair value of warrant liability (45,094)
Amortization of deferred financing costs 191,590
Non-cash PIK interest 30,393 143,731
Loss on sale of asset (56,215) (1,906)
Right-of-use assets, net of lease liabilities (4,001) 2,146
Changes in operating assets and liabilities:
Accounts receivable 25,305 11,825
Inventories 130,880 1,120,416
Prepaid and other current assets (1,208,888) (14,985)
Accounts payable (720,214) 567,390
Accrued liabilities 330,703 234,508
Accrued liabilities, related party (428,278) (6,200)
Contract liabilities (54,410)
Net cash used in operating activities (5,759,482) (570,882)
Cash flows from investing activities:
Proceeds from sale of assets 78,000
Capitalized expenditures (1,682,684) (88,368)
Net cash used in investing activities (1,682,684) (10,368)
Cash flows from financing activities:
Proceeds from convertible notes payable 10,150,000 1,350,000
Principal payments on financing lease (598,766) (597,117)
Proceeds from issuance on equity offerings 1,342,003
Payments on note payable (34,689) (564)
Debt issuance and deferred direct listing costs (970,000)
Net cash provided by financing activities 9,888,548 752,319
Net change to cash 2,446,382 171,069
Cash, beginning of period 2,477,122 434,613
Cash, end of period 4,923,504 605,682
Supplemental disclosure of cash flow information:
Cash paid for interest 203,009 262,496
Supplemental non-cash financing activities
Original issue discount on debt 5,465,385
Warrant liabilities recognized as debt discounts 2,592,796
Issuance of warrants in conjunction with convertible notes payable 586,813

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗